Crown Equity Holdings, Inc. (OTCBB:CRWE) disclosed that it is expanding its business by opening another office in Pakistan. This office will be located in the city of Attock, Pakistan. This office will add an additional workforce of 25 associates to its CRWENewswire team, which will increase the company’s up to date news and world affairs from the Mid-East, Far East and Europe online news wires.
The new office in the city of Attock, as well as the office in Islamabad, will be managed by Zeeshan Shabbir. Crown Equity Holdings is in the process of developing its Arabic language CRWENewswire site for news occurring in Pakistan and elsewhere around the world.
“As always, I am thrilled to increase our team of correspondents to offer our readerships a global perspective on top stories.” said Kenneth Bosket, President of Crown Equity Holdings Inc.
Crown Equity Holdings Inc. announced in June of this year its 1- 10 forward stock split, as well as in August announcing that the company had surpassed One Million dollars (1,000,000) in sales. Crown Equity Holdings Inc. is utilizing today’s technology to advertise, promote and market public companies globally.
Crown Equity Holdings’ proprietary network technology allows their publishing department to get their content to millions of readers daily across the world. Crown Equity Holdings Inc. publishes financial content to all the major countries and covers all the accredited stock exchanges. The goal for 2010 is to have all Crown Equity Holdings’ clients’ press releases, articles and news content published in every major financial country’s native language.
In addition to Crown Equity Holdings offering “I/R” service, Crown Equity Holdings has a dedicated in-house advertising server, allowing for faster response and a wider variety of ad space offerings to those interested in advertising on their numerous internet and affiliate internet properties.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Orofino Gold Corp. (ORFG.PK) is a US (Nevada) company established for the purpose of creating a significant exploration and mining group operating in Colombia. The second part of Orofino Gold’s strategy to become a recognized player in the Colombia mining sector was the acquisition of an interest in an operating mine. Orofino Gold has acquired a 55% interest in the La Azul/La Estrella property with the rights to acquire up to 80%.
La Azul is one producing artesanal mine in the Senderos de Oro area controlled by Orofino, it is a mixed sequence of predominantly volcanic rocks with the vien systems comprised of high grade chalcopyrite, galena and sphalerite with pyrite in quartz viens. The area is the site of economic mining activity and it is unlikely that the true grade of gold mineralization has been determined by the crude benefication methods employed by the resident miners.
The existing process of using mercury amalgamation to collect the free gold after grinding, followed by cyanide leach of the crushed material would not, for example, liberate gold tied up in the sulphides.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Alexza Pharmaceuticals Inc. (Nasdaq:ALXA) announced on Dec 7, 2010 that the Company has scheduled an End-of Review meeting with the U.S. Food and Drug Administration (FDA) in December to discuss the Complete Response Letter (CRL) regarding the Company’s New Drug Application (NDA) for AZ-004 (Staccato loxapine). Alexza has submitted an Information Package to the FDA in preparation for the meeting, with the responses or proposals to the issues raised in the CRL. AZ-004 is being developed for the rapid treatment of agitation in schizophrenia or bipolar disorder patients.
Alexza Pharmaceuticals, Inc., a development stage company, focuses on the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Biodel Inc. (Nasdaq:BIOD) announced on Dec 14, 2010 the retirement of Dr. Solomon Steiner as the company’s Chief Scientific Officer. Dr. Steiner is a co-founder of Biodel and will remain a member of the company’s board of directors. He served as Biodel’s chairman, president and chief executive officer from its founding in December 2003 until March 2010 when Dr. Errol De Souza was named the company’s president and chief executive officer and Dr. Charles Sanders was named board chairman.
Biodel Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Pressure BioSciences, Inc. (Nasdaq:PBIO) announced on Dec 14, 2010 the availability of three novel products targeted primarily for the drug discovery and development market. The new products were released at the 50thAnnual Meeting of the American Society for Cell Biology (ASCB) in Philadelphia, which began on Sunday December 12, 2010. Approximately 10,000 biologists from academia, government, the biotechnology industry, and pharmaceutical companies are expected to attend the ASCB meeting.
Pressure BioSciences, Inc., a life sciences company, engages in the development and commercialization of pressure cycling technology (PCT) in the United States.
No comments:
Post a Comment